[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.75.58. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Study
December 2005

Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study

Author Affiliations

Author Affiliations: Center for Clinical Epidemiology and Biostatistics (Drs Gelfand, Weinstein, Berlin, and Margolis), and Department of Dermatology (Drs Gelfand, Neimann, and Margolis and Mr Porter), University of Pennsylvania, Philadelphia.

Arch Dermatol. 2005;141(12):1537-1541. doi:10.1001/archderm.141.12.1537
Abstract

Objective  To measure the prevalence and treatment of psoriasis in the United Kingdom.

Design  Cross-sectional study to determine prevalence and cohort study to determine treatment patterns.

Setting  Outpatient practices of general practitioners.

Patients  We included in the analysis all patients who were registered with a general practitioner in the General Practice Research Database from 1987 to 2002.

Main Outcome Measures  The prevalence and treatment of psoriasis.

Results  We identified 114 521 patients with psoriasis of a total population of 7 533 475 patients, yielding a prevalence of 1.5%. The prevalence of psoriasis increases more rapidly in young female patients compared with young male patients and declines significantly in patients 70 years and older, regardless of sex. Overall, 91.8% of patients with a diagnosis of psoriasis received a prescription for psoriasis treatment on or after the date of their first diagnostic code of psoriasis in the General Practice Research Database. Most of the patients (55.2%) received only 1 or 2 prescriptions for psoriasis in the first year after psoriasis was documented in the General Practice Research Database.

Conclusions  The epidemiology of psoriasis in the General Practice Research Database population is similar to that of other epidemiologic studies of psoriasis performed in the United Kingdom, the United States, and other Western countries. Psoriasis carries a substantial burden given its high prevalence and its associated need for prescription therapy. Additional studies are necessary to determine why the prevalence of psoriasis increases more rapidly in female patients and to determine why the prevalence decreases in patients 70 years and older.

×